Illumina CEO on Genomic Sequencing Opportunities and AI

Written by BloombergPublished Jul 31, 2026, 8:51 PM

Illumina CEO Jacob Thaysen discusses the company's earnings, genomic medicine opportunities and the potential for artificial intelligence in life sciences on "Bloomberg The Close."

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs Explore Australia companies Find the right ASX index

Illumina CEO on Genomic Sequencing Opportunities and AI

More from Australia

Novatti reaches €1.2B quarterly transaction volume

OncoSil Medical revenue climbs 45.8% following approval

Clinuvel files European dossier for new drug

Australian foreign currency exposure reaches $2.25 trillion

Australians buy more fruit, fewer vegetables

DXN sales jump 380% to $3.4M in Q1 FY27

More ways to discover